ATLANTA, October 18, 2023--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Michael Rossi has informed the Company of his decision to resign as Medical Group President, effective November 1, 2023, in order to assume a CEO role at another public company.